Publications by authors named "Tim A Brighton"

Claim this Profile
O
Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials.
Martin H Prins, Anthonie W A Lensing, Tim A Brighton, Roger M Lyons, Jeffrey Rehm

Lancet Haematol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
Ximelagatran: direct thrombin inhibitor.
Shir-Jing Ho, Tim A Brighton

Vasc Health Risk Manag· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep-vein thrombosis.
Beng H Chong, Tim A Brighton, Ross I Baker, Peter Thurlow, Choon H Lee

J Thromb Thrombolysis· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased platelet-derived microparticles in the coronary circulation of percutaneous transluminal coronary angioplasty patients.
Judy A Craft, Paul P Masci, Michael S Roberts, Tim A Brighton, Paul Garrahy

Blood Coagul Fibrinolysis· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis